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Abstract
Purpose The COVID-19 pandemic has disrupted the health care system around the entire globe. A consensus is needed 
about resuming total hip and knee procedures. The European Hip Society (EHS) and the European Knee Association (EKA) 
formed a panel of experts that have produced a consensus statement on how the safe re-introduction of elective hip and knee 
arthroplasty should be undertaken.
Methods A prospective online survey was done among members of EHS and EKA. The survey consisted of 27 questions. 
It includes basic information on demographics and details the participant’s agreement with each recommendation. The 
participant could choose among three options (agree, disagree, abstain). Recommendations focussed on pre-operative, peri-
operative, and post-operative handling of patients and precautions.
Results A total of 681 arthroplasty surgeons participated in the survey, with 479 fully completing the survey. The partici-
pants were from 44 countries and 6 continents. Apart from adhering to National and Local Guidelines, the recommendations 
concerned how to make elective arthroplasty safe for patients and staff.
Conclusion The survey has shown good-to-excellent agreement of the participants with regards to the statements made in 
the recommendations for the safe return to elective arthroplasty following the first wave of the COVID-19 pandemic.
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Introduction
In recent months, the SARS-CoV-2 pandemic (COVID-19) 
has evolved rapidly in Europe, disrupting the personal, 
social, economic and professional lives of health profes-
sionals on a large scale. The overall goal of most govern-
ments in Europe has been to flatten the curve of infected 
SARS-CoV-2 patients and prevent a collapse of national 
health systems. The April 2020 SARS-CoV-2 survey com-
pleted by EHS and EKA members in Europe has confirmed 
the impact of SARS-CoV-2: this pandemic has resulted in 
a tremendous reduction in primary hip and knee arthro-
plasty procedures as shown in the survey. A broad con-
sensus is needed about the factors that need to be in place 
before restarting such procedures.
Delaying hip and knee arthroplasty in patients with 
severe osteoarthritis (OA) may lead to increased opi-
oid use. It is associated with lower clinical results and 
increased readmission rates after the index procedure. 
Moreover, when access to hip and knee arthroplasty is 
limited, as it is now in the wake of the COVID-19 sanitary 
measures, the direct and indirect costs for our health care 
and social systems are enormous. Many patients suffering 
from OA have to prolong their absence from work, request 
temporary unemployment benefits, and burden the public 
welfare system.
We are now entering a new phase in most European 
countries, where we can consider restarting elective hip 
and knee arthroplasty in a “post-pandemic” period. To 
date, the scientific basis for the existing guidelines is 
not robust; there is much room for an exchange of ideas 
between surgeons. The current concern is to map out the 
optimal trajectory for starting up elective hip and knee 
arthroplasties. As a result, the European Hip Society 
(EHS) and the European Knee Association (EKA) formed 
a panel of experts that have produced a consensus on how 
the safe re-introduction of elective arthroplasty should be 
undertaken. They have provided recommendations based 
on the available evidence [1]. This survey aimed to vali-
date the recommendations by involving arthroplasty sur-
geons from a wide geographical area to promote then the 
recommendations for a safe return to elective joint arthro-
plasty across Europe and elsewhere.
Materials and method
A prospective online survey was done online using Sur-
veyMonkey (Portland, USA: https ://www.surve ymonk 
ey.com) among members of European Hip Society (EHS) 
and European Knee Associates (EKA). A link to the sur-
vey was sent by email to all members of the EHS and 
the EKA and affiliated arthroplasty surgeons. The online 
survey was launched on 23rd May 2020 and concluded on 
6th June 2020.
The survey consisted of 27 questions. It includes basic 
information on demographics and details the participant’s 
agreement with each recommendation. The participant could 
choose among three options (agree, disagree, abstain). The 
recommendations focus on three time periods; pre-operative, 
per-operative, and post-operative (Table 1).
This survey did not require formal ethical approval with 
a practice dedicated to adult reconstruction.
Results
A total of 681 arthroplasty surgeons participated in the survey, 
with 479 fully completing the survey. The geographical spread 
of this survey included surgeons from 44 different countries 
in 6 continents (Fig. 1). The EHS and EKA had a 22.1% and 
20.9% response rate, respectively. The mean time in practice 
for all participants was 20 years (min 1 year–max 46 years).
The detailed results are shown in Table 2.
Discussion
The survey has shown good-to-excellent agreement by the 
participants to the Statements made in the Recommenda-
tions for the safe return to elective arthroplasty following the 
COVID-19 pandemic. Although the response rate from both 
the EHS and EKA membership was low, at around 20%, it 
is notable that the mean time in elective arthroplasty of the 
participants was 20 years. This means that very experienced 
surgeons gave their opinions. Coupled with the global cover-
age of the survey, the mean time in elective arthroplasty is a 
proper validation for the recommendations.
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Table 1  Questions and Statements from recommendations used in the survey
Questions Statements
Resuming elective hip and knee arthroplasty in the setting of the SARS-CoV-2 pandemic
1. When should elective hip and knee arthroplasty be 
resumed?
Elective hip and knee arthroplasty can be resumed when appropriate prerequisites 
concerning facilities, workforce, testing, supplies are met, and approval of local health 
authorities are obtained. Facilities in areas with low, or relatively low and stable 
incidence of SARS-CoV-2, can be allowed to provide care for patients needing non-
emergent, non-SARS-CoV-2 healthcare
2. Are new triage/patient selection criteria needed 
for hip and knee arthroplasty patients once elective 
surgery is resumed?
Increased demand for hip and knee arthroplasty, coupled with limited hospital resources, 
will force surgeons to select which patients will receive hip and knee arthroplasties 
sooner than others. This will entail employing objective, transparent criteria in prior-
itizing patient selection to identify the patients most in need who also have lower risk 
factors for disease transmission and post-operative complications
3. What are the priority indications for elective adult 
hip and knee reconstruction?
There is universal agreement regarding the indications for urgent hip and knee arthro-
plasty procedures, such as femoral neck fractures, periprosthetic fractures, dislocations 
and acute infection, even in the setting of the SARS-CoV-2 pandemic. However, prior-
ity indications for non-emergency procedures in primary and revision hip and knee 
arthroplasty are lacking and should be clarified
4. What is the role of outpatient hip and knee arthro-
plasty/enhanced recovery protocols in light of the 
SARS-CoV-2 pandemic?
It is universally accepted that shorter hospital stays and treatment in a SARS-CoV-2-free 
environment decrease the risk of SARS-CoV-2 infection in patients undergoing elec-
tive surgery. Performing hip and knee arthroplasty with enhanced recovery protocols 
that decrease the length of stay in a facility or can be used in ambulatory care centres 
to allow for day surgery might be beneficial for reducing the risk of viral transmission. 
Transitioning to enhanced recovery systems requires full support, adoption of all the 
subspecialties involved and the possible approval of health care payers, which may not 
be possible in the pandemic setting
5. What is the impact of delaying hip and knee arthro-
plasty for the patients themselves and for society?
Delaying elective hip and knee arthroplasty has negative consequences on the quality of 
life of patients and negatively impacts society as a whole. The benefits of hip and knee 
arthroplasty should be carefully weighed against the risks of viral transmission and 
infection, complications and mortality in the mostly elderly population requiring joint 
arthroplasty
Resuming elective hip and knee arthroplasty in the setting of the SARS-CoV-2 pandemic: pre-operative phase
1. What is the appropriate pre-operative clinical and 
laboratory screening and timeline for patients?
All patients undergoing surgery should have their temperature and oxygen saturation 
measured. A thorough medical history should be acquired and patients asked about 
any symptoms they may have, such as cough, fever, loss of smell or taste, headache 
or gastrointestinal disorders. Additionally, they should be questioned about recent 
travels and their occupation to stratify them into possible high-risk groups. Regarding 
the laboratory testing, it would be ideal for all patients to undergo RT-PCR testing for 
SARS-CoV-2 before the operation. However, local guidelines and the efficacy of tests 
must also be taken into consideration. If there is a paucity of available tests, then only 
high-risk patients should be tested. There is no indication for additional chest CT scans 
in the pre-operative screening. Time allowing, all surgical patients should apply social 
distancing principles for two full weeks prior to testing and the surgical procedure and 
self-quarantine in their home for the period between test acquisition and day of surgery
2. Is pre-operative tracking of patients, staff and rela-
tives necessary?
All patients and staff will need to be screened for potential symptoms of SARS-CoV-2 
prior to entering a hospital facility. In particular, staff must be routinely screened for 
potential symptoms. Isolation prior to surgery can be guided. All patients, staff and 
relatives, especially those with patient contact, need to be investigated for previous 
symptoms, travels abroad and possible contacts with populations at high-risk for 
SARS-CoV-2
3. Should spinal anaesthesia be routine? Spinal anaesthesia can be considered safer for every negatively screened patient (with or 
without a SARS-CoV-2 test) than general anaesthesia, since the latter requires airway 
manipulation and endotracheal intubation, procedures that can more easily transmit 
SARS-CoV-2
 – Should we only select patients as candidates who 
also consent to regional/spinal anaesthesia?
It cannot be made mandatory that patients consent to regional/spinal anaesthesia. Nev-
ertheless, the benefits of regional anaesthesia should be thoroughly explained to the 
patients, and whenever possible, this should be strongly considered as the preferred 
means of anaesthesia
 – If spinal anaesthesia does not occur, should we 
cancel the operation?
If general anaesthesia cannot be avoided, every precaution should be taken to avoid con-
tamination. If a SARS-CoV-2-negative environment has been achieved that is as secure 
as possible, then general anaesthesia with informed consent can be considered
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Table 1  (continued)
Questions Statements
4. If the SARS-CoV-2 tests are positive, how long 
should the hip or knee arthroplasty surgery be 
postponed?
It is reasonable to assume that patients who test positive for SARS-CoV-2 should not be 
operated on and should be discharged from the hospital. These patients should remain 
in quarantine at least 14 days and until a subsequent test turns out negative (two con-
firmed negative PCR swab tests with a 24 h interval) and they are free of fever, cough 
or other symptoms
5. What kind of back-up plan is needed to guarantee 
quality care and patient safety in this pandemic 
situation?
The treatment of SARS-CoV-2 patients is placing a huge strain on the resources of 
many hospitals, to the detriment of treatment of other health problems. Safety of hip 
and knee arthroplasty patients remains of paramount importance. Complications of 
cardiac and respiratory origin are the most common problems needing acute care. As 
elective operations begin, every hospital should have ICU capacity available to accept 
and accommodate patients with cardiopulmonary or other significant complications. 
It should be assumed that, after the resumption of normal functions at hospitals and in 
society in general, there will still be a risk of another outbreak of the disease. In such a 
situation, hospitals should be prepared to return to a “safe mode” with reorganization 
of the wards and personnel. Every hospital should have in place a plan for emergency 
distribution of the personnel and wards before elective surgery resumes
Resuming elective hip and knee arthroplasty in the setting of the SARS-CoV-2 pandemic: perioperative phase
1. Is there a need for:
 – Modification or reorganization of hospital wards 
(patient density, bed density, medical and nursing 
staff density, etc.)?
In most orthopaedic departments, the workforces have been adjusted to accommodate 
fewer cases, due to the reduction in trauma cases and cancellation of elective proce-
dures. As elective operations restart, the standard social distancing guidelines should 
be sufficient. Patient numbers in the clinical areas (wards, waiting areas, outpatient 
clinics) should be halved, with the patients spaced at least 2 m apart
 – Separation of elective and trauma orthopaedic 
surgery (with regard to the general orthopaedic 
departments)?
SARS-CoV-2 screening practices should ensure the health and safety of patients and 
staff. SARS-CoV-2-negative elective hip and knee arthroplasty must be separated from 
the SARS-COV-2-positive trauma unit. Since all patients undergoing elective proce-
dures are screened before administration and have tested negative for SARS-COV-2, 
they may be reluctant to go into certain settings for fear of viral transmission. There 
should be a physical separation of SARS-COV-2-positive and SARS-COV-2-negative 
patients and specific wards should be exclusively dedicated to treating patients with 
SARS-CoV-2 to reduce the risk of contaminating other patients
2. Should relatives/visitors or other supportive per-
sonnel be allowed onto the orthopaedic wards and 
operating suite?
Until normality returns, the number of visitors should be minimized as much as possible 
to reduce potential transmission of SARS-CoV-2 among patients, their family members 
and medical staff. This includes vendor representatives who travel to facilities to 
undergo, perform and support procedures. Limiting interactions between individuals 
and social distancing are part of the mainstream management against the spread of 
SARS-CoV-2. The number of visitors should be limited to those who are essential for 
a patient’s care. Although it is recognized that these rules create considerable anxiety 
for the patient, keeping all patients, relatives and staff safe from SARS-CoV-2 is the 
priority
3. Is there a need for extra disinfecting environmental 
procedures in between surgeries?
Standard protocols for cleaning and sterilizing instruments need to be meticulously 
applied
Moreover, once the patient has departed from the operating room, this should be left 
empty for a specific period of time and all high-touch surfaces, including the anaes-
thetic machine and the anaesthetic work area, should be cleaned and disinfected with 
an Environmental Protection Agency (EPA)-approved hospital disinfectant. The length 
of time in between patients depends on the number of air exchanges per hour in the 
room or space in question
4. What role do ultra-clean operating theatres, ortho-
paedic exhaust suits and ultraviolet light systems 
play in both the wards/beds and the theatre?
Elective orthopaedic theatres and operative procedures, including personal protective 
equipment, are designed to reduce the risk of surgical site infection. There are no 
guidelines or protocols published for managing elective hip and knee arthroplasty 
procedures with respect to laminar flow in the presence of SARS-CoV-2. It is recom-
mended that surgical helmets not be used as primary protection against aerosol and 
airborne disease. The surgeon should consider wearing an N95 mask as an added 
precaution when using a surgical helmet in patients considered to be SARS-CoV-
2-negative in the pre-operative work-up
Ultraviolet light has no evidence to support its routine use and poses a hazard to operat-
ing staff
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Conclusion
The survey has shown good-to-excellent agreement of the 
participants with regards to the statements made in the rec-
ommendations for the safe return to elective arthroplasty 
following the first wave of the COVID-19 pandemic.
Table 1  (continued)
Questions Statements
5. What are the guidelines for personal protective 
equipment (PPE), in terms of availability and 
instructions regarding its use and what to wear in 
relation to the patient’s position in the perioperative 
chain?
During hip and knee arthroplasty, the use of power tools, burrs or electrocautery gener-
ates potentially infective aerosol. The major aim should be to avoid transmission 
of SARS-CoV-2 by aerosolization of blood or other body fluids. Hence, adequate 
personal protective equipment should be available and used during surgery. First and 
foremost, all patients undergoing elective surgery should wear a mask. Surgeons and 
the entire surgical team who scrub during procedures should ideally wear an exhaust 
suit, including a mask (preferably N95, filtering face piece [FFP2, or P3] and a face 
shield). In the absence of a face shield, protective eyewear may be used, but this is a 
compromise. In addition, scrubs should be frequently changed during the surgical day. 
Single-use gowns, single-use gloves and hair and shoe covers can also, theoretically, 
reduce the transmission of the virus
Resuming elective hip and knee arthroplasty in the setting of the SARS-CoV-2 pandemic: post-operative phase
1. Since the impact on mind and body during joint 
arthroplasty is significant, our patients may have 
lower immunity and be more vulnerable to SARS-
CoV-2 infection
As SARS-CoV-2-positive is an absolute contra-indication for elective surgery, the stand-
ard enhanced recovery protocol for reducing complications is imperative
2.Organization of a shelter-in-place post-operative 
period, home care, community nurses or informal 
care
Ideally, patients should be discharged home with the standard SARS-CoV-2 precautions 
being taken and only transferred to a nursing home in cases where that is not possible, 
since higher rates of SARS-CoV-2 may exist in those facilities
3. Avoid face-to-face contact for the orthopaedic 
follow-up and physical therapy guidance
 –  Consider telemedicine
Web-based tools and telemedicine are preferred during this SARS-CoV-2 pandemic and 
may become the standard in the post-pandemic era
 – Consider a new approach in wound closure tech-
nique in the setting of the SARS-CoV-2 pandemic
Post-operative in-office visits should be minimized, and digital health programmes 
allowing health care providers to closely monitor patients remotely should be sup-
ported. Self-administered wound management should become the standard of care for 
patients in the post-pandemic era
4. What is the advice for patients who develop SARS-
CoV-2 symptoms?
In the event a patient develops SARS-CoV-2 symptoms or comes into contact with a 
SARS-CoV-2-positive person, they should seek health care advice. The patient should 
use the system in place in their country to seek the relevant advice. This may be 
through their primary care physician or an online or telephone advice service. Their 
orthopaedic surgeon and hospital should also be notified
5. Are special adjustments needed for post-op SARS-
CoV-2 prophylaxis?
Since SARS-CoV-2-positive is an absolute contraindication or elective surgery, the 
standard enhanced f recovery protocol and SARS-CoV-2 preventive measures are 
imperative. Time allowing, all surgical patients should apply social distancing princi-
ples for the first two weeks after the operation and self-quarantine in their home
Fig. 1  Geographical distribution of survey participants
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Table 2  Results of the survey








Resuming elective hip and knee arthroplasty in the setting of the SARS-CoV-2 pandemic
1. When should elective hip and knee arthroplasty be resumed? 653 (96) 18 (3) 10 (2) 681 (100)
2. Are new triage/patient selection criteria needed for hip and knee arthroplasty patients once elec-
tive surgery is resumes?
515 (82) 94 (15) 21 (3) 630 (93)
3. What are the priority indications for elective adult hip and knee reconstruction? 510 (83) 82 (13) 25 (4) 623 (92)
4. What is the role of outpatient hip and knee arthroplasty/enhanced recovery protocols in light of 
the SARS-CoV-2 pandemic?
450 (77) 76 (13) 59 (10) 585 (86)
5. What is the impact of delaying hip and knee arthroplasty for the patients themselves and for 
society?
530 (92) 27 (5) 19 (3) 576 (85)
Resuming elective hip and knee arthroplasty in the setting of the SARS-CoV-2 pandemic: preoperative phase
1. What is the appropriate preoperative clinical and laboratory screening and timeline for patients? 435 (80) 80 (15) 31 (6) 546 (80)
2. Is preoperative tracking of patients, staff and relatives necessary? 379 (71) 121 (23) 36 (7) 536 (79)
3. Should spinal anaesthesia be routine? 420 (79) 74 (14) 40 (8) 534 (78)
 – Should we only select patients as candidates who also consent to regional/spinal anaesthesia? 383 (72) 111 (21) 36 (7) 530 (78)
 – If spinal anaesthesia does not occur, should we cancel the operation? 384 (73) 108 (20) 37 (7) 539 (78)
4. If the SARS-CoV-2 tests are positive, how long should the hip or knee arthroplasty surgery be 
postponed?
474 (90) 29 (6) 24 (5) 527 (77)
5. What kind of back-up plan is needed to guarantee quality care and patient safety in this pandemic 
situation?
476 (92) 19 (4) 24 (5) 519 (76)
Resuming elective hip and knee arthroplasty in the setting of the SARS-CoV-2 pandemic: perioperative phase
1. Is there a need for
 – Modification or reorganization of hospital wards (patient density, bed density, medical and nurs-
ing stuff density, etc.)?
417 (81) 70 (14) 25 (5) 512 (75)
 – Separation of elective and trauma orthopaedic surgery (with regard to the general orthopaedic 
departments)?
449 (89) 36 (7) 20 (4) 505 (74)
2. Should relatives/visitors or other supportive personnel be allowed onto the orthopaedic wards and 
operating suite?
458 (91) 32 (6) 13 (2) 503 (74)
3. Is there a need for extra disinfecting environmental procedures in between surgeries? 341 (69) 107 (22) 48 (10) 496 (73)
4. What role do ultra-clean operating theatres, orthopaedic exhaust suits and ultraviolet light sys-
tems play in both the wards/beds and the theatre?
320 (65) 96 (20) 76 (16) 492 (72)
5. What are the guidelines for personal protective equipment (PPE), in terms of availability and 
instructions regarding its use and what to wear in relation to the patient’s position in the periop-
erative chain?
359 (74) 83 (17) 4 (9) 446 (65)
Resuming elective hip and knee arthroplasty in the setting of the SARS-CoV-2 pandemic: post-operative phase
1. Since the impact on mind and body during joint arthroplasty is significant, our patients may have 
lower immunity and be more vulnerable to SARS-CoV-2 infection
427 (88) 32 (7) 24 (5) 483 (71)
2.Organization of a shelter-in-place post-operative period, home care, community nurses or infor-
mal care
419 (87) 36 (8) 26 (5) 481 (71)
3. Avoid face-to-face contact for the orthopaedic follow-up and physical therapy guidance
 – Consider telemedicine
310 (65) 130 (27) 40 (8) 480 (70)
 – Consider a new approach in wound closure technique in the setting of the SARS-CoV-2 pan-
demic
299 (62) 141 (29) 39 (8) 479 (70)
4. What is the advice for patients who develop SARS-CoV-2 symptoms? 455 (95) 11 (2) 13 (3) 479 (70)
5. Are special adjustments needed for post-op SARS-CoV-2 prophylaxis? 362 (76) 86 (18) 31 (7) 479 (70)
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